Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons
- 1 May 1984
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 33 (5), 400-404
- https://doi.org/10.1016/0026-0495(84)90136-7
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patientsJAMA, 1982
- Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformationBiochemical and Biophysical Research Communications, 1982
- Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982
- Human leukocyte interferon produced by E. coli is biologically activeNature, 1980
- EFFECTS OF INTERFERON‐INDUCING AGENTS ON HEPATIC CYTOCHROME P‐450 DRUG METABOLIZING SYSTEMS*Annals of the New York Academy of Sciences, 1980
- Interferon and High-Density LipoproteinsNew England Journal of Medicine, 1980
- Interferon-induced enzymatic activities and their role in the antiviral stateCell, 1979
- Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement.Clinical Chemistry, 1978
- On the varied biologic effects of interferonCellular Immunology, 1977
- Effect of androgens on serum lipids and lipoproteinsLipids, 1972